Valuation: Kenvue Inc.

Market Cap 36.92B 32.33B 29.88B 27.57B 51.91B 3,552B 52.95B 357B 140B 1,736B 139B 136B 5,990B P/E 2026 *
20.2x
P/E 2027 * 18x
Enterprise Value 44.33B 38.82B 35.88B 33.1B 62.32B 4,264B 63.57B 428B 168B 2,084B 166B 163B 7,191B EV / Sales 2026 *
2.84x
EV / Sales 2027 * 2.73x
Free-Float
98.9%
Yield 2026 *
4.41%
Yield 2027 * 4.51%
1 day-2.44%
1 week-5.16%
Current month-1.83%
1 month+3.42%
3 months+7.94%
6 months+9.58%
Current year+8.75%
1 week 18.71
Extreme 18.71
19.86
1 month 17.86
Extreme 17.855
20.13
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
22.87
3 years 14.02
Extreme 14.02
25.23
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 14/07/2025
Director of Finance/CFO 48 12/05/2026
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 01/05/2023
Director/Board Member 66 04/05/2023
Director/Board Member 59 08/05/2023
Date Insider Type Main position Quantity % Market Cap.
06-29Free

Director

1,413 0.0001%
06-29
Starboard Value LP
OtherCompany 1,413 0.0001%
06-10Sell

Chief Financial Officer

-3,700 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-2.44%-5.16%-14.02%-24.78% 36.92B
-1.54%-4.37%-4.99%-2.65% 345B
-0.43%+0.15%-9.48%+2.09% 133B
-2.34%-4.21%+2.45%+19.09% 74.59B
-0.49%-3.71%-15.85%-20.13% 52.3B
-0.36%-4.24%-9.74%-58.24% 29.36B
-1.14%+3.15%-28.59%-32.97% 19.66B
-0.39%+1.05%+6.21%-0.43% 19.6B
+1.74%-1.44%-0.59%+23.11% 17.96B
-0.66%-3.54%-17.39%+0.76% 11.43B
Average -0.64%-0.98%-9.20%-9.42% 73.99B
Weighted average by Cap. -0.43%-0.67%-6.87%-4.22%

Financials

2026 *2027 *
Net sales 15.63B 13.68B 12.65B 11.67B 21.97B 1,503B 22.41B 151B 59.11B 735B 58.69B 57.39B 2,535B 16.02B 14.03B 12.97B 11.96B 22.52B 1,541B 22.98B 155B 60.61B 753B 60.18B 58.85B 2,599B
Net income 1.84B 1.61B 1.49B 1.38B 2.59B 177B 2.64B 17.8B 6.97B 86.63B 6.92B 6.77B 299B 2.06B 1.81B 1.67B 1.54B 2.9B 199B 2.96B 19.94B 7.81B 97.06B 7.76B 7.58B 335B
Net Debt 7.41B 6.49B 5.99B 5.53B 10.41B 712B 10.62B 71.54B 28.02B 348B 27.82B 27.2B 1,201B 6.81B 5.96B 5.51B 5.09B 9.58B 655B 9.77B 65.78B 25.76B 320B 25.58B 25.02B 1,105B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
14/07/26 $18.76 -2.44% 19,447,546
13/07/26 $19.23 -1.28% 39,873,974
10/07/26 $19.48 +1.56% 9,451,591
09/07/26 $19.18 -0.57% 14,446,508
08/07/26 $19.29 -2.48% 12,756,324
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
19.23USD
Average target price
19.58USD
Spread / Average Target
+1.84%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock